Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2000-1-4
pubmed:abstractText
To investigate the prognostic relevance of p21 and p27 protein expression in laryngeal squamous cell carcinoma (LSCC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3150-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10506612-Adult, pubmed-meshheading:10506612-Aged, pubmed-meshheading:10506612-Carcinoma, Squamous Cell, pubmed-meshheading:10506612-Cell Cycle, pubmed-meshheading:10506612-Cell Cycle Proteins, pubmed-meshheading:10506612-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:10506612-Cyclin-Dependent Kinase Inhibitor p27, pubmed-meshheading:10506612-Cyclins, pubmed-meshheading:10506612-Disease-Free Survival, pubmed-meshheading:10506612-Female, pubmed-meshheading:10506612-Gene Expression Regulation, Neoplastic, pubmed-meshheading:10506612-Humans, pubmed-meshheading:10506612-Immunohistochemistry, pubmed-meshheading:10506612-Laryngeal Neoplasms, pubmed-meshheading:10506612-Male, pubmed-meshheading:10506612-Microtubule-Associated Proteins, pubmed-meshheading:10506612-Middle Aged, pubmed-meshheading:10506612-Predictive Value of Tests, pubmed-meshheading:10506612-Prognosis, pubmed-meshheading:10506612-Retrospective Studies, pubmed-meshheading:10506612-Tumor Markers, Biological, pubmed-meshheading:10506612-Tumor Suppressor Proteins
pubmed:year
1999
pubmed:articleTitle
Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
pubmed:affiliation
II Servizio di Anatomia Patologica, Clinica Otorinolaringoiatrica I, Laboratorio Epidemiologico, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore di Milano, Milan, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't